Novanta Inc. (0VAG)
LSE 
Summary
0VAG Chart
Novanta Inc. (NOVT) M&A Call Transcript
Novanta Inc. (NOVT) M&A Call Transcript
Here's Why Novanta (NOVT) Looks Ripe for Bottom Fishing
Novanta (NOVT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Novanta (NOVT) Q1 Earnings and Revenues Surpass Estimates
Novanta (NOVT) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.74 per share a year ago.
Novanta Inc. (0VAG) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Novanta Inc. ever had a stock split?
Novanta Inc. Profile
| Automobile Components Industry | Consumer Discretionary Sector | Matthijs Glastra CEO | LSE Exchange | CA67000B1040 ISIN |
| US Country | 3,000 Employees | - Last Dividend | 29 Dec 2010 Last Split | 4 Jan 2016 IPO Date |
Overview
Novanta Inc., together with its subsidiaries, positions itself as a front-runner in delivering innovative solutions across precision medicine, manufacturing, medical sectors, and robotics and automation on a global scale. Diversifying its expertise into three main operational segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation, Novanta caters to a broad spectrum of technological needs. Originally operating as GSI Group, Inc., the company underwent a rebranding to Novanta Inc. in May 2016, marking a significant milestone in its global journey since its foundation in 1968. Headquartered in Bedford, Massachusetts, Novanta’s expansive product offerings are marketed worldwide through a mix of direct sales forces and distributor networks under renowned brand names, including Cambridge Technology, Synrad, Laser Quantum, and many others, signifying a commitment to quality and innovation in their sector.
Products and Services
Precision Medicine and Manufacturing: Novanta’s portfolio in this segment includes photonics-based solutions such as laser scanning, beam delivery, CO2 lasers, solid state lasers, ultrafast lasers, and optical light engines. These products find application in industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures, underscoring the company’s role in advancing precision medicine and manufacturing technologies.
Medical Solutions: This segment delivers medical grade technologies encompassing medical insufflators, pumps, and disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations. Plus, it offers optical data collection and machine vision technologies, radio frequency identification technologies, thermal chart recorders, spectrometry technologies, and embedded touchscreen solutions, illustrating Novanta’s commitment to enhancing medical care and procedures through technology.
Robotics and Automation: Novanta excels in providing optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, and intelligent robotic end-of-arm technology solutions, alongside air bearings and air bearing spindles. Such offerings underscore the company’s dedication to innovation in robotics and automation, streamlining operations and improving efficiency across various industrial applications.
